The neurobiology of binge-like ethanol drinking: Evidence from rodent models

Physiology and Behavior

Volumn 106, Issue 3, 2012, Pages 325-331

  Sprow, Gretchen M ^a   Thiele, Todd E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Binge; C57BL 6J; DID; Ethanol

Indexed keywords

AGOUTI RELATED PROTEIN; ALCOHOL; CORTICOTROPIN RELEASING FACTOR; GHRELIN; NEUROPEPTIDE Y;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; DRINKING BEHAVIOR; NEUROBIOLOGY; NONHUMAN; PREDICTIVE VALIDITY; PRIORITY JOURNAL;

AGOUTI-RELATED PROTEIN; ALCOHOL DRINKING; ANIMALS; BINGE-EATING DISORDER; CORTICOTROPIN-RELEASING HORMONE; GHRELIN; HUMANS; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEUROBIOLOGY;

EID: 84860465524     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.12.026     Document Type: Article

References (73)

1. CDC Alcohol-attributable deaths and years of potential life lost - United States, 2001. MMWR Morb Mortal Wkly Rep 2004, 866-870.
2. Hines L.M., Ray L., Hutchison K., Tabakoff B. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 2005, 7:153-163.
3. NIAAA NIAAA council approves definition of binge drinking. NIAAA Newslett Winter 2004, 3:3.
4. Nelson D.E., Naimi T.S., Brewer R.D., Nelson H.A. State alcohol-use estimates among youth and adults, 1993-2005. Am J Prev Med 2009, 36:218-224.
5. Naimi T.S., Brewer R.D., Mokdad A., Denny C., Serdula M.K., Marks J.S. Binge drinking among US adults. JAMA 2003, 289:70-75.
6. Fan A.Z., Russell M., Stranges S., Dorn J., Trevisan M. Association of lifetime alcohol drinking trajectories with cardiometabolic risk. J Clin Endocrinol Metab 2008, 93:154-161.
7. Okoro C.A., Brewer R.D., Naimi T.S., Moriarty D.G., Giles W.H., Mokdad A.H. Binge drinking and health-related quality of life: do popular perceptions match reality?. Am J Prev Med 2004, 26:230-233.
8. Miller J.W., Naimi T.S., Brewer R.D., Jones S.E. Binge drinking and associated health risk behaviors among high school students. Pediatrics 2007, 119:76-85.
9. Naimi T.S., Lipscomb L.E., Brewer R.D., Gilbert B.C. Binge drinking in the preconception period and the risk of unintended pregnancy: implications for women and their children. Pediatrics 2003, 111:1136-1141.
10. Hingson R.W., Heeren T., Winter M.R. Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics 2006, 118:e755-e763.
11. Hingson R.W., Heeren T., Winter M.R. Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch Pediatr Adolesc Med 2006, 160:739-746.
12. Spanagel R. Recent animal models of alcoholism. Alcohol Res Health 2000, 24:124-131.
13. Cicero T.J. A critique of animal analogue of alcoholism. Biochemistry and pharmacology of ethanol 1979, 533-560. Plenum Press, New York. E. Majchrowichz, P. Noble (Eds.).
14. Lester D, Freed E. Criteria for an animal model of alcoholism. 1973,1: 103-107.
15. Bell R.L., Rodd Z.A., Smith R.J., Toalston J.E., Franklin K.M., McBride W.J. Modeling binge-like ethanol drinking by peri-adolescent and adult P rats. Pharmacol Biochem Behav 2011, 100:90-97.
16. Faingold C.L. The Majchrowicz Binge Alcohol Protocol: an intubation technique to study alcohol dependence in rats. Current protocols in neuroscience 2001, John Wiley & Sons, Inc.
17. Coleman L.G., He J., Lee J., Styner M., Crews F.T. Adolescent binge drinking alters adult brain neurotransmitter gene expression, behavior, brain regional volumes, and neurochemistry in mice. Alcohol Clin Exp Res 2011, 35:671-688.
18. Finn D.A., Belknap J.K., Cronise K., Yoneyama N., Murillo A., Crabbe J.C. A procedure to produce high alcohol intake in mice. Psychopharmacology (Berl) 2005, 178:471-480.
19. Tanchuck M.A., Yoneyama N., Ford M.M., Fretwell A.M., Finn D.A. Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. Alcohol 2011, 45:33-44.
20. Szumlinski K.K., Diab M.E., Friedman R., Henze L.M., Lominac K.D., Bowers M.S. Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology (Berl) 2007, 190:415-431.
21. Cozzoli D.K., Goulding S.P., Zhang P.W., Xiao B., Hu J.H., Ary A.W., et al. Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J Neurosci 2009, 29:8655-8668.
22. Simms J.A., Steensland P., Medina B., Abernathy K.E., Chandler L.J., Wise R., et al. Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res 2008, 32:1816-1823.
23. Hwa L.S., Chu A., Levinson S.A., Kayyali T.M., DeBold J.F., Miczek K.A. Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res. 2011, 35:1938-1947.
24. Rhodes J.S., Best K., Belknap J.K., Finn D.A., Crabbe J.C. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 2005, 84:53-63.
25. Rhodes J.S., Ford M.M., Yu C.H., Brown L.L., Finn D.A., Garland T., et al. Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav 2007, 6:1-18.
26. Ho A., Chin A. Circadian feeding and drinking patterns of genetically obese mice fed solid chow diet. Physiol Behav 1988, 43:651-656.
27. Crabbe J.C., Spence S.E., Brown L.L., Metten P. Alcohol preference drinking in a mouse line selectively bred for high drinking in the dark. Alcohol 2011, 45:427-440.
28. Crabbe J.C., Metten P., Rhodes J.S., Yu C.H., Brown L.L., Phillips T.J., et al. A line of mice selected for high blood ethanol concentrations shows drinking in the dark to intoxication. Biol Psychiatry 2009, 65:662-670.
29. Sparrow AM, Lowery-Gionta EG, Pleil KE, Li C, Sprow GM, Cox BR et al. Central Neuropeptide Y Modulates Binge-Like Ethanol Drinking in C57BL/6J Mice via Y1 and Y2 Receptors. Neuropsychopharmacology. Advance online publication 4 January 2012, doi:. doi:10.1038/npp.2011.327.
30. Lyons A.M., Lowery E.G., Sparta D.R., Thiele T.E. Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 2008, 32:1962-1968.
31. Linsenbardt D.N., Boehm S.L. Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area. Neuroscience 2009, 164:424-434.
32. Sajja R.K., Rahman S. Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:257-264.
33. Heilig M., Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 2006, 111:855-876.
34. Bouza C., Angeles M., Munoz A., Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004, 99:811-828.
35. Gupta T., Syed Y.M., Revis A.A., Miller S.A., Martinez M., Cohn K.A., et al. Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice. Alcohol Clin Exp Res 2008, 32:1992-1998.
36. Melon L.C., Boehm S.L. GABAA receptors in the posterior, but not anterior, ventral tegmental area mediate Ro15-4513-induced attenuation of binge-like ethanol consumption in C57BL/6J female mice. Behav Brain Res 2011, 220:230-237.
37. Moore E.M., Serio K.M., Goldfarb K.J., Stepanovska S., Linsenbardt D.N., Boehm S.L. GABAergic modulation of binge-like ethanol intake in C57BL/6J mice. Pharmacol Biochem Behav 2007, 88:105-113.
38. Moore E.M., Boehm S.L. Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/6J mice. Behav Neurosci 2009, 123:555-563.
39. Koob G.F. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 2003, 27:232-243.
40. Mendez M., Morales-Mulia M. Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr Drug Abuse Rev 2008, 1:239-252.
41. Kamdar N.K., Miller S.A., Syed Y.M., Bhayana R., Gupta T., Rhodes J.S. Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice. Psychopharmacology (Berl) 2007, 192:207-217.
42. Bulwa Z.B., Sharlin J.A., Clark P.J., Bhattacharya T.K., Kilby C.N., Wang Y., et al. Increased consumption of ethanol and sugar water in mice lacking the dopamine D2 long receptor. Alcohol 2011, 45:631-639.
43. Romberger D.J., Grant K. Alcohol consumption and smoking status: the role of smoking cessation. Biomed Pharmacother 2004, 58:77-83.
44. DiFranza J.R., Guerrera M.P. Alcoholism and smoking. J Stud Alcohol 1990, 51:130-135.
45. Steensland P., Simms J.A., Holgate J., Richards J.K., Bartlett S.E. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 2007, 104:12518-12523.
46. Soderpalm B., Ericson M., Olausson P., Blomqvist O., Engel J.A. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 2000, 113:85-96.
47. Hendrickson L.M., Zhao-Shea R., Tapper A.R. Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice. Psychopharmacology (Berl) 2009, 204:563-572.
48. Ericson M., Blomqvist O., Engel J.r.A., Sderpalm B. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol 1998, 358:189-196.
49. Erdozain A.M., Callado L.F. Involvement of the endocannabinoid system in alcohol dependence: the biochemical, behavioral and genetic evidence. Drug Alcohol Depend 2011, 117:102-110.
50. Li Z., Kang S.S., Lee S., Rivier C. Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression. Mol Cell Neurosci 2005, 29:345-354.
51. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
52. Sparta D.R., Sparrow A.M., Lowery E.G., Fee J.R., Knapp D.J., Thiele T.E. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 2008, 32:259-265.
53. Lowery E.G., Spanos M., Navarro M., Lyons A.M., Hodge C.W., Thiele T.E. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 2010, 35:1241-1252.
54. Ryabinin A.E., Yoneyama N., Tanchuck M.A., Mark G.P., Finn D.A. Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience 2008, 151:780-790.
55. Kaur S, Li J, Stenzel-Poore MP, Ryabinin AE. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcohol Clin Exp Res. First published online 6 September 2011, doi:. doi:10.1111/j.1530-0277.2011.01610.x.
56. Navarro M., Cubero I., Knapp D.J., Breese G.R., Thiele T.E. Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcohol Clin Exp Res 2008, 32:266-276.
57. Ploj K., Roman E., Kask A., Hyytia P., Schioth H.B., Wikberg J., et al. Effects of melanocortin receptor ligands on ethanol intake and opioid levels in alcohol-preferring AA rats. Brain Res Bull 2002, 59:97-104.
58. Navarro M., Cubero I., Ko L., Thiele T.E. Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes Brain Behav 2009, 8:450-458.
59. Thiele T.E., Sparta D.R., Fee J.R., Navarro M., Cubero I. Central neuropeptide Y alters ethanol-induced sedation, but not ethanol intake, in C57BL/6 mice. Alcohol 2003, 31:155-160.
60. Kaur S., Ryabinin A.E. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res 2010, 34:1525-1534.
61. Yi C.X., Heppner K., Tschop M.H. Ghrelin in eating disorders. Mol Cell Endocrinol 2011, 340:29-34.
62. McBride W.J., Kimpel M.W., Schultz J.A., McClintick J.N., Edenberg H.J., Bell R.L. Changes in gene expression in regions of the extended amygdala of alcohol-preferring rats after binge-like alcohol drinking. Alcohol 2010, 44:171-183.
63. Bell R.L., Rodd Z.A., Lumeng L., Murphy J.M., McBride W.J. The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 2006, 11:270-288.
64. Bell R.L., Kimpel M.W., McClintick J.N., Strother W.N., Carr L.G., Liang T., et al. Gene expression changes in the nucleus accumbens of alcohol-preferring rats following chronic ethanol consumption. Pharmacol Biochem Behav 2009, 94:131-147.
65. Bell R.L., Kimpel M.W., Rodd Z.A., Strother W.N., Bai F., Peper C.L., et al. Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol. Alcohol 2006, 40:3-17.
66. Kosten T.A. Pharmacologically targeting the P2rx4 gene on maintenance and reinstatement of alcohol self-administration in rats. Pharmacol Biochem Behav 2011, 98:533-538.
67. Ostrovskaya O., Asatryan L., Wyatt L., Popova M., Li K., Peoples R.W., et al. Ethanol is a fast channel inhibitor of P2X4 receptors. J Pharmacol Exp Ther 2011, 337:171-179.
68. Xiao C., Zhou C., Li K., Davies D.L., Ye J.H. Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action. J Pharmacol Exp Ther 2008, 327:196-205.
69. Boehm S.L., Moore E.M., Walsh C.D., Gross C.D., Cavelli A.M., Gigante E., et al. Using drinking in the dark to model prenatal binge-like exposure to ethanol in C57BL/6J mice. Dev Psychobiol 2008, 50:566-578.
70. Mulligan M.K., Rhodes J.S., Crabbe J.C., Mayfield R.D., Adron Harris R., Ponomarev I. Molecular profiles of drinking alcohol to intoxication in C57BL/6J mice. Alcohol Clin Exp Res 2011, 35:659-670.
71. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 2006, 26:11324-11332.
72. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 2007, 61:78-86.
73. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.